1.96 USD
▼+0.05-0.51%
盘后 1.94 -1.71%
2026-08-03
市值
$44.42M
市盈率
—
EPS
-14.19
股息率
—
52 周区间
1.80 – 10.99
成交量
3.79M
Beta
0.91
目标价
13.20
52W 低 1.8052W 高 10.99
价格走势
公司简介
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compounds include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myelom...